{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:20:13Z","timestamp":1792819213247,"version":"4.5.0"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2024,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Primary urethral urothelial carcinoma is a rare aggressive tumor with a high propensity for local invasion and regional and distal metastases. We describe the usefulness of FDG PET\/CT in management of a patient with primary urethral urothelial carcinoma. FDG PET\/CT at initial staging showed FDG-avid primary tumor and lymph node metastasis of the left groin, and mild or no activity of the lung metastases due to small size. FDG PET\/CT after 4 cycles of chemotherapy showed progression of the primary tumor and lung metastases, partial response of the left inguinal lymphadenopathy, and multiple new sites of FDG-avid metastases.<\/jats:p>","DOI":"10.1097\/rlu.0000000000005362","type":"journal-article","created":{"date-parts":[[2024,7,5]],"date-time":"2024-07-05T17:00:08Z","timestamp":1720198808000},"page":"1048-1049","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":7,"title":["FDG PET\/CT in Staging and Response Evaluation of Primary Urothelial Carcinoma of the Urethra"],"prefix":"10.1097","volume":"49","author":[{"given":"Jun","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Cardiothoracic Surgery, The Second Affiliated Hospital, Jiaxing University, Jiaxing, Zhejiang Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aisheng","family":"Dong","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, The First Affiliated Hospital of Naval Medical University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Shanghai Fourth People\u2019s Hospital Affiliated to Tongji University School of Medicine, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,7,1]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"3935","DOI":"10.1007\/s00261-019-02127-8","article-title":"Multimodality imaging of the male urethra: trauma, infection, neoplasm, and common surgical repairs","volume":"44","year":"2019","journal-title":"Abdom Radiol (NY)"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.humpath.2017.08.006","article-title":"Carcinoma of the urethra","volume":"72","year":"2018","journal-title":"Hum Pathol"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"102606","DOI":"10.1016\/j.fjurol.2024.102606","article-title":"Primary urethral carcinoma: recommendations of the oncology committee of the French Urology Association","volume":"34","year":"2024","journal-title":"Fr J Urol"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/10668969211032481","article-title":"A contemporary clinicopathologic analysis of primary urothelial carcinoma of the urethra without concurrent renal pelvic, ureteral, or bladder carcinoma","volume":"30","year":"2022","journal-title":"Int J Surg Pathol"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"700","DOI":"10.3390\/cancers11050700","article-title":"18F-FDG PET\/CT and urothelial carcinoma: impact on management and prognosis\u2014a multicenter retrospective study","volume":"11","year":"2019","journal-title":"Cancers (Basel)"},{"key":"bib6-20250621","first-page":"59","article-title":"Performance of fluoro-2-deoxy-D-glucose positron emission tomography-computed tomography imaging for lymph node staging in bladder and upper tract urothelial carcinoma: a systematic review","volume":"19","year":"2020","journal-title":"Arab J Urol"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1053\/j.semnuclmed.2021.12.004","article-title":"PET\/CT in bladder cancer: an update","volume":"52","year":"2022","journal-title":"Semin Nucl Med"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"606","DOI":"10.3390\/ph16040606","article-title":"PET imaging in bladder cancer: an update and future direction","volume":"16","year":"2023","journal-title":"Pharmaceuticals (Basel)"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1159\/000381269","article-title":"Clinical value of 18F-Fluorodeoxyglucose positron emission tomography\/computed tomography in upper tract urothelial carcinoma: impact on detection of metastases and patient management","volume":"96","year":"2016","journal-title":"Urol Int"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.euo.2019.09.004","article-title":"Diagnostic value of (18)F-fluorodeoxyglucose positron emission tomography with computed tomography for lymph node staging in patients with upper tract urothelial carcinoma","volume":"3","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/RLU.0b013e3181c36234","article-title":"Interesting image. Two primary colon cancers shown on FDG PET\/CT performed to evaluate possible lung metastases from bladder cancer","volume":"35","year":"2010","journal-title":"Clin Nucl Med"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1097\/RLU.0000000000003779","article-title":"FDG PET\/CT in a case of lynch syndrome with synchronous inverted urothelial papilloma of the bladder, urothelial carcinoma of the ureter, and jejunal adenocarcinoma","volume":"47","year":"2022","journal-title":"Clin Nucl Med"},{"key":"bib13-20250621","doi-asserted-by":"crossref","first-page":"e575","DOI":"10.1097\/RLU.0000000000004873","article-title":"Initial staging and response evaluation with 18F-FDG PET\/CT in a rare case of nested variant urothelial urethral cancer","volume":"48","year":"2023","journal-title":"Clin Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005362","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T15:07:39Z","timestamp":1750518459000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000005362"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,1]]},"references-count":13,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000005362","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,1]]}}}